These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 26095183)

  • 1. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
    J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
    J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
    Hou MF; Luo CW; Chang TM; Hung WC; Chen TY; Tsai YL; Chai CY; Pan MR
    Exp Cell Res; 2017 Oct; 359(2):458-465. PubMed ID: 28842166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of mTOR signaling in hepatocellular carcinoma.
    Villanueva A; Chiang DY; Newell P; Peix J; Thung S; Alsinet C; Tovar V; Roayaie S; Minguez B; Sole M; Battiston C; Van Laarhoven S; Fiel MI; Di Feo A; Hoshida Y; Yea S; Toffanin S; Ramos A; Martignetti JA; Mazzaferro V; Bruix J; Waxman S; Schwartz M; Meyerson M; Friedman SL; Llovet JM
    Gastroenterology; 2008 Dec; 135(6):1972-83, 1983.e1-11. PubMed ID: 18929564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc finger protein X-linked promotes expansion of EpCAM
    Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP
    Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
    Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
    Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
    Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
    J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
    Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
    Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4.
    Polo SE; Kaidi A; Baskcomb L; Galanty Y; Jackson SP
    EMBO J; 2010 Sep; 29(18):3130-9. PubMed ID: 20693977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
    Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
    Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
    Xia H; Chen J; Shi M; Gao H; Sekar K; Seshachalam VP; Ooi LL; Hui KM
    J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.
    Zou J; Li H; Huang Q; Liu X; Qi X; Wang Y; Lu L; Liu Z
    Tumour Biol; 2017 Oct; 39(10):1010428317719272. PubMed ID: 29025375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
    Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
    J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.